KLF17 and cancer: FACS analysis showed that HepG2 cells were less susceptible to cisplatin-induced apoptosis when KLF17 was depleted (Figure 6f), suggesting that KLF17 may increase cellular sensitivity to anti-cancer chemotherapy.